Cargando…
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
BACKGROUND: There are inconsistencies in the literature regarding the prevalence and assessment of chemotherapy-induced peripheral neuropathy (CIPN). This study explored CIPN natural history and its characteristics in patients receiving taxane- and platinum-based chemotherapy. PATIENTS AND METHODS:...
Autores principales: | Molassiotis, Alex, Cheng, Hui Lin, Lopez, Violeta, Au, Joseph S. K., Chan, Alexandre, Bandla, Aishwarya, Leung, K. T., Li, Y. C., Wong, K. H., Suen, Lorna K. P., Chan, Choi Wan, Yorke, Janelle, Farrell, Carole, Sundar, Raghav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368751/ https://www.ncbi.nlm.nih.gov/pubmed/30736741 http://dx.doi.org/10.1186/s12885-019-5302-4 |
Ejemplares similares
-
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019) -
Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
por: Wang, Mian, et al.
Publicado: (2019) -
Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
por: Cheng, Hui Lin, et al.
Publicado: (2020) -
A Limb Hypothermia Wearable for Chemotherapy-Induced Peripheral Neuropathy: A Mixed-Methods Approach in Medical Product Development
por: Binder, Jonathan, et al.
Publicado: (2020) -
Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
por: Jia, Junting, et al.
Publicado: (2021)